Inspire Medical Systems
INSP
55.10
-1.18
-2.10%
Inspire Medical Systems
US · INSP
#2781 by market cap
Listed 2018
55.10
-1.18
-2.10%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Mizuho Securities Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $75Market Newswire · 2026/10/13
-
Rating change
RBC Capital Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Raises Target Price to $75Market Newswire · 2026/10/1
-
Rating change
RBC Capital Initiates Inspire Medical Systems(INSP.US) With Hold Rating, Announces Target Price $75Market Newswire · 2026/10/3
-
Rating change
Barclays Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Announces Target Price $65Market Newswire · 2026/10/7
-
Rating change
J.P. Morgan Remains a Hold on Inspire Medical Systems (INSP)TipRanks · 2026/8/4
-
Rating change
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $54Market Newswire · 2026/7/16
-
Rating change
Stifel Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $80Market Newswire · 2026/9/14
-
Company notice
Puyuan Information: Independent financial adviser's opinion of Minsheng Securities Co., Ltd. on insider information related to Puyuan Information Technology Co., Ltd.'s termination of major asset restructuring matters and stock trading during the self-inspSZSI · 2021/3/24
-
Rating change
Freedom Capital Markets Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $97Market Newswire · 2026/9/21
-
Barclays Maintains Inspire Medical Systems(INSP.US) With Sell Rating, Cuts Target Price to $62Market Newswire · 2026/11/3
-
A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $62 to $85Market Newswire · 2026/11/4
-
Rating change
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Raises Target Price to $78Market Newswire · 2026/10/14
-
Rating change
UBS Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Cuts Target Price to $39Market Newswire · 2026/7/28
-
KeyBanc Maintains Inspire Medical Systems(INSP.US) With Hold RatingMarket Newswire · 2026/11/3
-
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Raises Target Price to $69Market Newswire · 2026/11/3
-
Rating change
A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $45 to $85Market Newswire · 2026/8/5
-
Rating change
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $56Market Newswire · 2026/7/4
-
UBS Maintains Inspire Medical Systems(INSP.US) With Sell Rating, Raises Target Price to $45Market Newswire · 2026/11/6
-
Rating change
Stifel Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $85Market Newswire · 2026/9/23
-
Rating change
Stifel Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $80Market Newswire · 2026/9/11
-
Rating change
Freedom Capital Markets Initiates Inspire Medical Systems(INSP.US) With Buy Rating, Announces Target Price $62Market Newswire · 2026/7/2
-
Rating change
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $56Market Newswire · 2026/5/6
-
Rating change
KeyBanc Maintains Inspire Medical Systems(INSP.US) With Hold RatingMarket Newswire · 2026/8/4
-
Rating change
Oppenheimer Maintains Inspire Medical Systems(INSP.US) With Hold RatingMarket Newswire · 2026/5/7
-
Rating change
BofA Securities Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Cuts Target Price to $39Market Newswire · 2026/5/22
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Inspire Medical Systems discussion 0 comments